Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,859.00    42.00 (2.31%)
Bid:
1,856.00
Ask:
1,858.00
Spread: 2.00 (0.108%)
Market Cap: £2.08b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Annual Information Update

19 May 2008 11:30

RNS Number : 7535U
Derwent London PLC
19 May 2008
 

DERWENT LONDON PLC (THE "COMPANY")

ANNUAL INFORMATION UPDATE FOR THE 

12 MONTHS UP TO 16 MAY 2008

This annual information update is filed pursuant to Prospectus Rule 5.2 made by the Financial Services Authority and not for any other purpose and by filing this annual information update neither the Company, nor any other person, takes any responsibility for, or makes any representation, express or implied, as to the accuracy or completeness of, the information contained or referred to below herein. The information referred to below is not necessarily up to date as at the date of this annual information update and the Company does not undertake any obligation to update any such information in the future. Furthermore, such information may have been prepared in accordance with the laws or regulations of a particular jurisdiction and may not comply with or meet the relevant standards of disclosure in any other jurisdiction. Neither this annual information update, nor the information referred to below constitutes, by virtue of this communication, an offer of any securities addressed to any person and should not be relied on by any person.

1. Announcements made via a Regulatory Information Service

The following regulatory announcements have been made by the Company via a Regulatory Information Service during the previous 12 months. Copies of these announcements can be found on the Company's market news pages on the London Stock Exchange website at www.londonstockexchange.com.

Time/Date Filed

Headline

13/05/2008

Notice of IMS

28/04/2008

Blocklisting Interim Review

23/04/2008

Annual Report

18/03/2008

Final Results

29/02/2008

Planning Consent

21/02/2008

Notice of Results 

13/02/ 2008

Planning Permission

12/02/2008

Transfer of Bond Listing

31/01/2008

Holding(s) in Company

21/01/2008

Holding(s) in Company

21/01/2008

Planning consent received

10/01/2008

Director/PDMR Shareholding

08/01/2008

Re: Letting

04/01/2008

Directorate Change

02/01/2008

Total Voting Rights

31/12/2007

Director/PDMR Shareholding

21/12/2007

Director/PDMR Shareholding

30/11/2007

Director/PDMR Shareholding

22/11/2007

Director/PDMR Shareholding

22/11/2007

Director/PDMR Shareholding

22/11/2007

Director/PDMR Shareholding

22/11/2007

Director/PDMR Shareholding

22/11/2007

Director/PDMR Shareholding

05/11/2007

Blocklisting Interim Review

05/11/2007

Holding(s) in Company

24/09/2007

Doc re. Interim Report

20/09/2007

Director/ PDMR Shareholding

11/09/2007

Interim Results

16/08/2007

Annual Information Update

16/08/2007

Notice of Results

30/07/2007

Bondholders Presentation

13/07/2007

Re: Sales

29/06/2007

Total Voting Rights

26/06/2007

EGM results

18/06/2007

Directorate Change

31/05/2007

Publication of Circular

23/05/2007

Filing of Documents with UKLA

23/05/2007

AGM Statement

2. Documents filed with the Registrar of Companies

The following documents listed below were filed with the Registrar of Companies during the previous 12 months. Copies can be obtained from Companies House:

Companies House

Crown Way

Cardiff CF14 3UZ

Telephone 0870 333 636

Email: enquiries@companies-house.gov.uk

Or through Companies House Direct at www.direct.companieshouse.gov.uk.

Date Filed

Form

Document Description

07/01/2008

288a

New Director appointed

19/12/2007

88(2)R

Allotment of 129,393 shares

04/10/2007

288c

Director's particulars changed 

04/10/2007

288c

Director's particulars changed 

23/07/2007

288b

Director resigned

14/07/2007

RES 01

Alteration to Memorandum and Articles

13/07/2007

88(2)R

Allotment of 5,000 shares

28/06/2007

395

Particulars of Mortgage/Charge

18/06/2007

363s

Annual Return to 1 June 2007 

18/06/2007

AA

2006 Annual Report and Accounts 

06/06/2007

RES 10

Special business resolutions passed at the annual general meeting on the 23 May 2007

15/05/2007

88(2)R

 Allotment of 2,077 shares

3. Documents published and sent to Shareholders and filed with the UK Listing Authority document viewing facility:

The following documents have been filed by the Company with the Financial Services Authority during the previous 12 months. These documents may be viewed at the UK Listing Authority's Document Viewing Facility at 25 The North Colonnade, Canary WharfLondon E14 5HS. Copies of these documents are also available on request from the Company's registered office at 25 Savile Row, London W1S 2ER.

Date Published, 

Posted & Filed

Document Description

23/04/2008

2007 Annual report and accounts

23/04/2008

Notice of the AGM

24/09/2007

2007 Interim Report

31/05/2007

Conversion to REIT status

Copies of the Annual and Interim Report & Accounts, along with further information about the Company and its activities, are available on the Company's website: 

www.derwentlondon.com

A copy of this annual information update is available on request from the Company's registered office at: 

25 Savile Row

London, W1S 2ER.

For further information, please contact: TJ Kite

Company Secretary

Telephone: 020 7659 3000

16 May 2008

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUSFIFSUSASESI
Date   Source Headline
12th Aug 20257:00 amRNSBoard Change
12th Aug 20257:00 amRNSInterim Results
5th Aug 20257:00 amRNSNew headlease agreed at 50 Baker Street W1
31st Jul 20254:45 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSDisposal of Francis House SW1 for £55.5m
25th Jul 20257:00 amRNSExtension of £450m Revolving Credit Facility
30th Jun 20254:45 pmRNSTotal Voting Rights
18th Jun 20257:00 amRNSAdobe lease extension and expansion
12th Jun 202511:00 amRNSRedemption of £175 million Convertible Bonds
30th May 20254:45 pmRNSTotal Voting Rights
29th May 202511:15 amRNSHolding(s) in Company
23rd May 20254:05 pmRNS£250m 7-year 5.25% bond issuance
16th May 202512:00 pmRNSResults of 2025 Annual General Meeting
8th May 20257:00 amRNSFirst Quarter Business Update
1st May 202510:00 amRNSAnnual Bondholder Meeting
30th Apr 20254:45 pmRNSTotal Voting Rights
15th Apr 202510:00 amRNSAnnual Financial Report
9th Apr 20253:00 pmRNSAdditional Listing
31st Mar 20254:45 pmRNSTotal Voting Rights
31st Mar 202510:00 amRNSNotice of Q1 2025 Business Update
26th Mar 20251:00 pmRNSDirector/PDMR Shareholding
20th Mar 20254:45 pmRNSBlock listing Interim Review
7th Mar 20252:00 pmRNSDirector/PDMR Shareholding
4th Mar 20255:15 pmRNSDirector/PDMR Shareholding
28th Feb 20254:45 pmRNSTotal Voting Rights
27th Feb 20257:00 amRNSResults for the Year Ended 31 December 2024
31st Jan 20254:45 pmRNSTotal Voting Rights
30th Jan 20255:35 pmRNSHolding(s) in Company
27th Jan 20251:30 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNS25 Baker Street W1 offices fully pre-let
31st Dec 202412:45 pmRNSTotal Voting Rights
3rd Dec 20247:00 amRNSAcquisition
29th Nov 20244:45 pmRNSTotal Voting Rights
7th Nov 20247:00 amRNSTHIRD QUARTER BUSINESS UPDATE
5th Nov 202412:44 pmRNSHolding(s) in Company
31st Oct 20244:45 pmRNSTotal Voting Rights
23rd Oct 20245:30 pmRNSHolding(s) in Company
16th Oct 202410:30 amRNSDirectorate Change
30th Sep 20244:45 pmRNSTotal Voting Rights
20th Sep 20244:45 pmRNSBlock listing Interim Review
19th Sep 202411:00 amRNSDirector/PDMR Shareholding
17th Sep 202411:03 amRNSHolding(s) in Company
30th Aug 20244:45 pmRNSTotal Voting Rights
23rd Aug 202411:15 amRNSAdditional Listing
8th Aug 20247:00 amRNSHalf-Year Results
31st Jul 20244:45 pmRNSTotal Voting Rights
28th Jun 20244:45 pmRNSTotal Voting Rights
12th Jun 202411:00 amRNSHolding(s) in Company
10th Jun 20244:00 pmRNSDirector/PDMR Shareholding
31st May 20244:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.